{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:16:37Z","timestamp":1768011397876,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2010,4,14]],"date-time":"2010-04-14T00:00:00Z","timestamp":1271203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2010,4,14]],"date-time":"2010-04-14T00:00:00Z","timestamp":1271203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s00115-009-2918-7","type":"journal-article","created":{"date-parts":[[2010,4,12]],"date-time":"2010-04-12T13:49:11Z","timestamp":1271080151000},"page":"837-843","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Vorzeitige Immunalterung: ein pathogenetischer Faktor bei Alzheimer-Demenz?","Premature immunosenescence: a pathogenetic factor in Alzheimer\u2019s disease?"],"prefix":"10.1007","volume":"81","author":[{"given":"E.","family":"Richartz-Salzburger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Stransky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Laske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,14]]},"reference":[{"key":"2918_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"Akiyama","year":"2000","unstructured":"Akiyama H, Barger S, Barnum S et al (2000) Inflammation and Alzheimer\u2019s disease. Neuroinflammation working group. Neurobiol Aging 21:383\u2013421","journal-title":"Neurobiol Aging"},{"key":"2918_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/jcla.1860040106","volume":"4","author":"Antonaci","year":"1990","unstructured":"Antonaci S, Garofalo AR, Chicco C et al (1990) Senile dementia, Alzheimer type: a distinct entity in the immunosenescence? J Clin Lab Anal 4:16\u201321","journal-title":"J Clin Lab Anal"},{"key":"2918_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/jemt.1121","volume":"54","author":"Bamberger","year":"2001","unstructured":"Bamberger ME, Landreth GE (2001) Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer\u2019s disease. Microsc Res Tech 54:59\u201370","journal-title":"Microsc Res Tech"},{"key":"2918_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2165\/00002512-200320020-00002","volume":"20","author":"Blasko","year":"2003","unstructured":"Blasko I, Grubeck-Loebenstein B (2003) Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer\u2019s disease. Drugs Aging 20:101\u2013113","journal-title":"Drugs Aging"},{"key":"2918_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2174\/187152709787601867","volume":"8","author":"Dean","year":"2009","unstructured":"Dean R, Bell RD, Sagare A, Zklokovic BV (2009) Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer\u2019s disease. CNS Neurol Disord Drug Targets 8(1):16\u201330","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"2918_CR6","doi-asserted-by":"publisher","first-page":"8850","DOI":"10.1073\/pnas.151261398","volume":"19","author":"DeMattos","year":"2001","unstructured":"DeMattos RB, Bales KR, Cummins DJ et al (2001) Peripheral anti-A-beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 19:8850\u20138855","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2918_CR7","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/labinvest.3780140","volume":"80","author":"De","year":"2000","unstructured":"De la Monte SM, Luong T, Neely TR et al (2000) Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer disease. Lab Invest 80:1323\u20131335","journal-title":"Lab Invest"},{"key":"2918_CR8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1212\/WNL.57.5.801","volume":"57","author":"Du","year":"2001","unstructured":"Du Y, Dodel R, Hampel H (2001) Reduced levels of amyloid beta-peptide antibody in Alzheimer disease. Neurology 57:801\u2013805","journal-title":"Neurology"},{"key":"2918_CR9","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1086\/301845","volume":"62","author":"Effros","year":"1998","unstructured":"Effros RB (1998) Replicative senescence in the immune system: Impact of the Hayflick limit on T cell function in the elderly. Am J Hum Genet 62:1003\u20131007","journal-title":"Am J Hum Genet"},{"key":"2918_CR10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3233\/JAD-2005-7304","volume":"7","author":"Fiala","year":"2005","unstructured":"Fiala M, Lin J, Ringman J et al (2005) Ineffective phagocytosis of amyloid-\u03b2 by macrophages of Alzheimer\u2019s disease patients. J Alzheimers Dis 7:221\u2013232","journal-title":"J Alzheimers Dis"},{"key":"2918_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1749-6632.1992.tb38643.x","volume":"663","author":"Franceschi","year":"1992","unstructured":"Franceschi C, Monti D, Scarfi MR et al (1992) Genomic instability and aging. Studies in centenarians (successful aging) and in patients with Down\u2019s syndrome (accelerated aging). Ann N Y Acad Sci 663:4\u201316","journal-title":"Ann N Y Acad Sci"},{"key":"2918_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1742-2094-5-51","volume":"11","author":"Giunta","year":"2008","unstructured":"Giunta B, Fernandez F, Nikolic WV et al (2008) Inflammaging as a prodrome to Alzheimer\u2019s disease. J Neuroinflammation 11:51","journal-title":"J Neuroinflammation"},{"key":"2918_CR13","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/s00115-008-2491-5","volume":"79","author":"Grimmer","year":"2008","unstructured":"Grimmer T, Perneczky R, Kurz A (2008) Aktueller Stand der Immuntherapie bei Alzheimer-Krankheit. Nervenarzt 79:822\u2013845","journal-title":"Nervenarzt"},{"key":"2918_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0531-5565(01)00190-5","volume":"37","author":"Guayerbas","year":"2002","unstructured":"Guayerbas N, Puerto M, Victor VM et al (2002) Leukocyte function and life span in a murine model of premature immunosenescence. Exp Gerontol 37:249\u2013256","journal-title":"Exp Gerontol"},{"key":"2918_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: Progress and problems on the road to therapeutics. Science 297:353\u2013356","journal-title":"Science"},{"key":"2918_CR16","unstructured":"Jenner E (1798) An inquiry into the causes and effects of the variolae vaccine, or cow-pox. In: The three original publications on vaccination against smallpox. Vol. XXXVIII, Part 4 (2001). Collier PF, Son Bartleby.com, The Harvard Classics, New York, pp 1909\u20131014"},{"key":"2918_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1750-3639.1993.tb00761.x","volume":"3","author":"Kalaria","year":"1993","unstructured":"Kalaria RN (1993) The immunopathology of Alzheimer\u2019s disease and some related disorders. Brain Pathol 3:333\u2013347","journal-title":"Brain Pathol"},{"key":"2918_CR18","first-page":"Epub","volume":"18","author":"Lee","year":"2009","unstructured":"Lee M, Sparatore A, Del Soldato P et al (2009) Hydrogen sulfide-releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation. Glia 18: Epub ahead of print","journal-title":"Glia"},{"key":"2918_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2174\/156720508785908946","volume":"5","author":"Mancuso","year":"2008","unstructured":"Mancuso M, Orsucci D, Siciliano G, Murri L (2008) Mitochondria, mitochondrial DNA and Alzheimer\u2019s disease. What comes first? Curr Alzheimer Res 5:457\u2013468","journal-title":"Curr Alzheimer Res"},{"key":"2918_CR20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0197-4580(01)00289-5","volume":"22","author":"McGeer","year":"2001","unstructured":"McGeer PL, McGeer EG (2001) Inflammation, autotoxicity and Alzheimer\u2019s disease. Neurobiol Aging 22:799\u2013809","journal-title":"Neurobiol Aging"},{"key":"2918_CR21","doi-asserted-by":"crossref","unstructured":"Nandy K (1977) Immune reactions in aging brain and senile dementia. In: Nandy K, Sherwin I (eds) The aging brain and senile dementia. Plenum, New York, pp 181\u2013196","DOI":"10.1007\/978-1-4684-3093-6_11"},{"key":"2918_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0197-4580(02)00043-X","volume":"24","author":"Panossian","year":"2003","unstructured":"Panossian LA, Porter VR, Valenzuela HF et al (2003) Telomere shortening in T cells correlates with Alzheimer disease status. Neurobiol Aging 24:77\u201384","journal-title":"Neurobiol Aging"},{"key":"2918_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1006\/clim.2000.4834","volume":"95","author":"Park","year":"2000","unstructured":"Park E, Alberti J, Mehta P et al (2000) Partial impaired immune functions in peripheral blood leukocytes from aged men with Down\u2019s syndrome. Clin Immunol 95:62\u201369","journal-title":"Clin Immunol"},{"key":"2918_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3109\/00207459809003341","volume":"95","author":"Popovic","year":"1998","unstructured":"Popovic M, Caballero-Bleda M, Puelles L, Popovic N (1998) Importance of immunological and inflammatory processes in the pathogenesis and therapy of Alzheimer\u2019s disease. Int J Neurosci 95:203\u2013236","journal-title":"Int J Neurosci"},{"key":"2918_CR25","first-page":"145","volume":"11","author":"Richartz","year":"2004","unstructured":"Richartz E, Klein R, Stransky E et al (2004) Autoantibody reactivity in serum and cerebrospinal fluid of patients with Alzheimer\u2019s disease. Neurol Psychiat Brain Res 11:145\u2013148","journal-title":"Neurol Psychiat Brain Res"},{"key":"2918_CR26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000083497","volume":"19","author":"Richartz","year":"2005","unstructured":"Richartz E, Batra A, Stransky E et al (2005) Diminished production of proinflammatory cytokines in patients with Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 19:184\u2013188","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2918_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2006.10.012","volume":"41","author":"Richartz","year":"2007","unstructured":"Richartz E, Batra A, Stransky E et al (2007) Altered lymphoycyte distribution in Alzheimer\u2019s disease. J Psychiatr Res 41:1\u20138","journal-title":"J Psychiatr Res"},{"key":"2918_CR28","unstructured":"Richartz-Salzburger E (2008) Psychoimmunologische Forschung bei Alzheimer-Demenz. Monographien aus dem Gesamtgebiete der Psychiatrie. Bd 114. Steinkopff, Darmstadt"},{"key":"2918_CR29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/22124","volume":"400","author":"Schenk","year":"1999","unstructured":"Schenk D, Barbour R, Dunn W et al (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173\u2013177","journal-title":"Nature"},{"key":"2918_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0047-6374(86)90043-6","volume":"37","author":"Singh","year":"1986","unstructured":"Singh VK, Fudenberg HH, Brown FR (1986\u20131987) Immunologic dysfunction: Simultaneous study of Alzheimer\u2019s and older Down\u2019s patients. Mech Ageing Dev 37:257\u2013264","journal-title":"Mech Ageing Dev"},{"key":"2918_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000213837","volume":"43","author":"Singh","year":"1997","unstructured":"Singh VK (1997) Neuroautoimmunity: Pathogenetic implications for Alzheimer\u2019s disease. Gerontology 43:79\u201394","journal-title":"Gerontology"},{"key":"2918_CR32","first-page":"519","volume":"8","author":"Solomon","year":"2007","unstructured":"Solomon B (2007) Antibody-mediated immunotherapy for Alzheimer\u2019s disease. Curr Opin Investig Drugs 8:519\u2013524","journal-title":"Curr Opin Investig Drugs"},{"key":"2918_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/glia.10154","volume":"40","author":"Streit","year":"2002","unstructured":"Streit WJ (2002) Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40:133\u2013139","journal-title":"Glia"},{"key":"2918_CR34","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1212\/01.wnl.0000263217.36439.da","volume":"68","author":"Tan","year":"2007","unstructured":"Tan ZS, Beiser AS, Vasan RS et al (2007) Inflammatory markers and the risk of Alzheimer disease: the framingham study. Neurology 68:1902\u20131908","journal-title":"Neurology"},{"key":"2918_CR35","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0166-2236(86)90077-9","volume":"9","author":"Wekerle","year":"1986","unstructured":"Wekerle H, Linington C, Lassmann H, Meyermann R (1986) Cellular immune reactivity within the CNS. Trends Neurosci 9:271\u2013277","journal-title":"Trends Neurosci"},{"key":"2918_CR36","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/00146965-200309000-00004","volume":"16","author":"Zhang","year":"2003","unstructured":"Zhang J, Kong Q, Zhang Z et al (2003) Telomere dysfunction of lymphocytes in patients with Alzheimer\u2019s disease. Cogn Behav Neurol 16:170\u2013176","journal-title":"Cogn Behav Neurol"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-009-2918-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-009-2918-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-009-2918-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-009-2918-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T15:15:44Z","timestamp":1684854944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-009-2918-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,14]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["2918"],"URL":"https:\/\/doi.org\/10.1007\/s00115-009-2918-7","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,14]]},"assertion":[{"value":"14 April 2010","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}